HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maiter, D. Articles by Ketelslegers, J.-M. Search for Related Content PubMed PubMed Citation Articles by Maiter, D. Articles by Ketelslegers, J.-M.

To define the mechanism(s) for the decrease of somatomedin concentrations in acute protein malnutrition, we have assessed the relationships between serum immunoreactive somatomedin-C/insulin-like growth factor-I (Sm-C/IGF-I), serum immunoreactive GH and total (MgCl₂-treated homogenates) as well as free (water-treated homogenates) liver somatogenic (GH) binding sites in growing rats fed a 5% protein diet for 12 or 24 h and given an s.c. injection(s) of rat GH (rGH) or saline. Control rats were fed a 15% protein diet and injected with rGH or saline.

After 12 and 24 h of protein restriction, body weight was 6·9 and 8·2% below controls respectively (P < 0·001), while Sm-C/IGF-I concentrations were reduced by 58 and 66% respectively (P < 0·001 vs controls). Serum GH concentrations were not affected by the low protein intake. Furthermore, injection(s) of 50–100 µg rGH failed to raise serum Sm-C/IGF-I concentrations in the protein-deficient animals. The number of total and free GH-binding sites was modestly (15–20%) decreased at 12 and 24 h in the protein-restricted rats. Serum Sm-C/IGF-I concentrations correlated weakly with free and total binding sites (r = 0·48 and 0·38 respectively). Affinity constants of GH-binding sites were not changed by protein restriction.

The profound reduction in Sm-C/IGF-I concentrations within a few hours of beginning protein restriction, and the discordance between this reduction and the small decline in somatogenic binding sites, suggests that, in addition to GH receptor loss, a postreceptor defect may participate in the GH resistance occurring in the early stages of protein deficiency.

J. Endocr. (1988) 118, 113–120

This article has been cited by other articles:

				D. Defalque, N. Brandt, J.-M. Ketelslegers, and J.-P. Thissen GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E565 - E572. [Abstract] [Full Text] [PDF]

				S. Jain, D. W. Golde, R. Bailey, and M. E. Geffner Insulin-Like Growth Factor-I Resistance Endocr. Rev., October 1, 1998; 19(5): 625 - 646. [Abstract] [Full Text]

				M. Darling-Raedeke, W. H. Thornton Jr, and R. S. MacDonald Growth Hormone and IGF-I Plasma Concentrations and Macronutrient Intake Measured in a Free-Living Elderly Population During a One-Year Period J. Am. Coll. Nutr., August 1, 1998; 17(4): 392 - 397. [Abstract] [Full Text] [PDF]